[1]
“Tablet Splitting Performance Evaluation of Losartan Potassium and Olmesartan Medoxomil IR Tablets Marketed in Bangladesh”, Bangla Pharma J, vol. 23, no. 2, pp. 146–154, Jul. 2020, doi: 10.3329/bpj.v23i2.48335.